HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanoparticles of 5-fluorouracil (5-FU) loaded N-succinyl-chitosan (Suc-Chi) for cancer chemotherapy: preparation, characterization--in-vitro drug release and anti-tumour activity.

Abstract
N-Succinyl-chitosan has favourable properties as a drug carrier, such as biocompatibility, low toxicity and long-term retention in the body. It is a good candidate for cancer chemotherapy as a polymeric drug carrier. This study describes the preparation and characterization of 5-fluorouracil-loaded N-succinyl-chitosan nanoparticles (5-FU-Suc-Chi/NP) by an emulsification solvent diffusion method. The influence of the initial 5-FU concentration on the nanoparticle characteristics and release behaviour in phosphate-buffered saline solution (PBS) was evaluated. The Suc-Chi nanoparticles had a particle diameter (Z-average) in the range 202 approximately 273 nm and a negative zeta-potential (approx. -27 to -18 mV). The formulation with an initial 5-FU concentration of 1000 microg mL-1 provided the highest loading capacity (19%) and the highest extent of release (61% at 24 h). The 5-FU-Suc-Chi/NP showed good anti-tumour activity against Sarcoma 180 solid tumour and mild toxicity. According to the data obtained, this Suc-Chi-based nanotechnology opens new and interesting perspectives for cancer chemotherapy.
AuthorsChengyun Yan, Dawei Chen, Jiwei Gu, Jing Qin
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 58 Issue 9 Pg. 1177-81 (Sep 2006) ISSN: 0022-3573 [Print] England
PMID16945175 (Publication Type: Journal Article)
Chemical References
  • Antimetabolites, Antineoplastic
  • Colloids
  • Delayed-Action Preparations
  • Drug Carriers
  • N-succinyl-chitosan
  • Chitosan
  • Fluorouracil
Topics
  • Animals
  • Antimetabolites, Antineoplastic (chemistry, therapeutic use)
  • Chitosan (chemistry)
  • Colloids
  • Delayed-Action Preparations
  • Diffusion
  • Drug Carriers
  • Drug Compounding
  • Fluorouracil (chemistry, therapeutic use)
  • Mice
  • Mice, Inbred BALB C
  • Nanoparticles
  • Neoplasm Transplantation
  • Particle Size
  • Sarcoma 180 (drug therapy, pathology)
  • Solubility
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: